Ceftazidime DALI Pharma 1 g Powder for Solution for Injection/Infusion Малта - английски - Medicines Authority

ceftazidime dali pharma 1 g powder for solution for injection/infusion

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftazidime pentahydrate - solution for injection/infusion - ceftazidime pentahydrate 1 g - antibacterials for systemic use

Ceftriaxone DALI Pharma 2 g Powder for Solution for Infusion Малта - английски - Medicines Authority

ceftriaxone dali pharma 2 g powder for solution for infusion

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for infusion - ceftriaxone sodium 2 g - antibacterials for systemic use

Ceftriaxone DALI Pharma 250 mg Powder for Solution for Injection Малта - английски - Medicines Authority

ceftriaxone dali pharma 250 mg powder for solution for injection

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 250 mg - antibacterials for systemic use

Ceftriaxone DALI Pharma 500 mg Powder for Solution for Injection Малта - английски - Medicines Authority

ceftriaxone dali pharma 500 mg powder for solution for injection

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 500 mg - antibacterials for systemic use

Ceftriaxone DALI Pharma 1 g Powder for Solution for Injection Малта - английски - Medicines Authority

ceftriaxone dali pharma 1 g powder for solution for injection

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftriaxone sodium - powder for solution for injection - ceftriaxone sodium 1 g - antibacterials for systemic use

Docetaxel Venus Pharma 20 mg/1 ml concentrate for solution for infusion (1ml vial) Малта - английски - Medicines Authority

docetaxel venus pharma 20 mg/1 ml concentrate for solution for infusion (1ml vial)

venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - concentrate for solution for infusion - docetaxel 20 mg/ml - antineoplastic agents

Docetaxel Venus Pharma 20 mg/1 ml concentrate for solution for infusion (4ml vial) Малта - английски - Medicines Authority

docetaxel venus pharma 20 mg/1 ml concentrate for solution for infusion (4ml vial)

venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - concentrate for solution for infusion - docetaxel 20 mg/ml - antineoplastic agents

Docetaxel Venus Pharma 20 mg/1 ml concentrate for solution for infusion (8ml vial) Малта - английски - Medicines Authority

docetaxel venus pharma 20 mg/1 ml concentrate for solution for infusion (8ml vial)

venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - concentrate for solution for infusion - docetaxel 20 mg/ml - antineoplastic agents

PHARMAGABAPENTIN gabapentin 300 mg capsule blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

pharmagabapentin gabapentin 300 mg capsule blister pack

pharmacor pty ltd - gabapentin, quantity: 300 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.

PHARMAGABAPENTIN gabapentin 400 mg capsule blister pack Австралия - английски - Department of Health (Therapeutic Goods Administration)

pharmagabapentin gabapentin 400 mg capsule blister pack

pharmacor pty ltd - gabapentin, quantity: 400 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.